SREBF1 and fatty liver disease: Clostridia_UCG-014 likely converts primary bile acids to secondary forms through 7α-dehydroxylation, subsequently activating FXR signalling to inhibit SREBP-1c-mediated lipogenesis, thereby alleviating hepatic steatosis [37].